BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26817896)

  • 1. Mesopancreatic Stromal Clearance Defines Curative Resection of Pancreatic Head Cancer and Can Be Predicted Preoperatively by Radiologic Parameters: A Retrospective Study.
    Wellner UF; Krauss T; Csanadi A; Lapshyn H; Bolm L; Timme S; Kulemann B; Hoeppner J; Kuesters S; Seifert G; Bausch D; Schilling O; Vashist YK; Bruckner T; Langer M; Makowiec F; Hopt UT; Werner M; Keck T; Bronsert P
    Medicine (Baltimore); 2016 Jan; 95(3):e2529. PubMed ID: 26817896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesopancreatic excision for pancreatic ductal adenocarcinoma improves local disease control and survival.
    Safi SA; Haeberle L; Fluegen G; Lehwald-Tywuschik N; Krieg A; Keitel V; Luedde T; Esposito I; Rehders A; Knoefel WT
    Pancreatology; 2021 Jun; 21(4):787-795. PubMed ID: 33775563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of R Status in Resections for Pancreatic Cancer Using Simplified Radiological Criteria.
    Bolm L; Pisuchpen N; Qadan M; Kambadakone A; Sondermann S; Mueller K; Petruch N; May K; Zelga P; Nebbia M; Michelakos T; Baba T; Roldan J; Harrison JM; Honselmann KC; Keck T; Lillemoe KD; Ferrone CR; Wellner UF; Fernandez-Del Castillo C
    Ann Surg; 2022 Aug; 276(2):215-221. PubMed ID: 36036988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of at least 1 mm as cut-off for resection margins for pancreatic adenocarcinoma of the body and tail.
    Hank T; Hinz U; Tarantino I; Kaiser J; Niesen W; Bergmann F; Hackert T; Büchler MW; Strobel O
    Br J Surg; 2018 Aug; 105(9):1171-1181. PubMed ID: 29738626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining distal splenopancreatectomy by the mesopancreas.
    Safi SA; Alexander A; Neuhuber W; Haeberle L; Rehders A; Luedde T; Esposito I; Fluegen G; Knoefel WT
    Langenbecks Arch Surg; 2024 Apr; 409(1):127. PubMed ID: 38625602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-Operative MDCT Staging Predicts Mesopancreatic Fat Infiltration-A Novel Marker for Neoadjuvant Treatment?
    Safi SA; Haeberle L; Heuveldop S; Kroepil P; Fung S; Rehders A; Keitel V; Luedde T; Fuerst G; Esposito I; Ziayee F; Antoch G; Knoefel WT; Fluegen G
    Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503170
    [No Abstract]   [Full Text] [Related]  

  • 7. Predictive factors for long-term survival after surgery for pancreatic ductal adenocarcinoma: Making a case for standardized reporting of the resection margin using certified cancer center data.
    Weyhe D; Obonyo D; Uslar VN; Stricker I; Tannapfel A
    PLoS One; 2021; 16(3):e0248633. PubMed ID: 33735191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic Cancer Surgery: The New R-status Counts.
    Strobel O; Hank T; Hinz U; Bergmann F; Schneider L; Springfeld C; Jäger D; Schirmacher P; Hackert T; Büchler MW
    Ann Surg; 2017 Mar; 265(3):565-573. PubMed ID: 27918310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A preoperative risk model for early recurrence after radical resection may facilitate initial treatment decisions concerning the use of neoadjuvant therapy for patients with pancreatic ductal adenocarcinoma.
    Guo SW; Shen J; Gao JH; Shi XH; Gao SZ; Wang H; Li B; Yuan WL; Lin L; Jin G
    Surgery; 2020 Dec; 168(6):1003-1014. PubMed ID: 32321665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The predictive value and role of stromal tumor-infiltrating lymphocytes in pancreatic ductal adenocarcinoma (PDAC).
    Lianyuan T; Dianrong X; Chunhui Y; Zhaolai M; Bin J
    Cancer Biol Ther; 2018 Apr; 19(4):296-305. PubMed ID: 29313457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective assessment of resection margin status following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma after standardisation of margin definitions.
    Pine JK; Haugk B; Robinson SM; Darne A; Wilson C; Sen G; French JJ; White SA; Manas DM; Charnley RM
    Pancreatology; 2020 Apr; 20(3):537-544. PubMed ID: 31996296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of resection margin status on recurrence and survival in pancreatic cancer surgery.
    Tummers WS; Groen JV; Sibinga Mulder BG; Farina-Sarasqueta A; Morreau J; Putter H; van de Velde CJ; Vahrmeijer AL; Bonsing BA; Mieog JS; Swijnenburg RJ
    Br J Surg; 2019 Jul; 106(8):1055-1065. PubMed ID: 30883699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic adenocarcinoma: quantitative CT features are correlated with fibrous stromal fraction and help predict outcome after resection.
    Cai X; Gao F; Qi Y; Lan G; Zhang X; Ji R; Xu Y; Liu C; Shi Y
    Eur Radiol; 2020 Sep; 30(9):5158-5169. PubMed ID: 32346792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgery after FOLFIRINOX treatment for locally advanced and borderline resectable pancreatic cancer: increase in tumour attenuation on CT correlates with R0 resection.
    Marchegiani G; Todaro V; Boninsegna E; Negrelli R; Sureka B; Bonamini D; Salvia R; Manfredi R; Pozzi Mucelli R; Bassi C
    Eur Radiol; 2018 Oct; 28(10):4265-4273. PubMed ID: 29679211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal Assessment of Prognostic Factors in Patients With Pancreatic Ductal Adenocarcinoma Undergoing Neoadjuvant Treatment and Resection.
    Ren W; Xourafas D; Ashley SW; Clancy TE
    J Surg Res; 2021 Jan; 257():605-615. PubMed ID: 32947122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of Resection Margin Involvement After Pancreaticoduodenectomy for Ductal Adenocarcinoma: Updates From a French Prospective Multicenter Study.
    Delpero JR; Jeune F; Bachellier P; Regenet N; Le Treut YP; Paye F; Carrere N; Sauvanet A; Adham M; Autret A; Poizat F; Turrini O; Boher JM
    Ann Surg; 2017 Nov; 266(5):787-796. PubMed ID: 28953554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Tumor Location on Resection and Survival for Pancreatic Ductal Adenocarcinoma.
    Winer LK; Dhar VK; Wima K; Morris MC; Lee TC; Shah SA; Ahmad SA; Patel SH
    J Surg Res; 2019 Jul; 239():60-66. PubMed ID: 30802706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reappraisal of Total Pancreatectomy in 45 Patients With Pancreatic Ductal Adenocarcinoma in the Modern Era Using Matched-Pairs Analysis: Multicenter Study Group of Pancreatobiliary Surgery in Japan.
    Satoi S; Murakami Y; Motoi F; Sho M; Matsumoto I; Uemura K; Kawai M; Kurata M; Yanagimoto H; Yamamoto T; Mizuma M; Unno M; Kinoshita S; Akahori T; Shinzeki M; Fukumoto T; Hashimoto Y; Hirono S; Yamaue H; Honda G; Kwon M
    Pancreas; 2016 Aug; 45(7):1003-9. PubMed ID: 26692442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. R0 Versus R1 Resection Matters after Pancreaticoduodenectomy, and Less after Distal or Total Pancreatectomy for Pancreatic Cancer.
    Demir IE; Jäger C; Schlitter AM; Konukiewitz B; Stecher L; Schorn S; Tieftrunk E; Scheufele F; Calavrezos L; Schirren R; Esposito I; Weichert W; Friess H; Ceyhan GO
    Ann Surg; 2018 Dec; 268(6):1058-1068. PubMed ID: 28692477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Para-aortic lymph nodes and ductal adenocarcinoma of the pancreas: Distant neighbors?
    Safi SA; Rehders A; Haeberle L; Fung S; Lehwald N; Esposito I; Ziayee F; Krieg A; Knoefel WT; Fluegen G
    Surgery; 2021 Dec; 170(6):1807-1814. PubMed ID: 34392977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.